BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29203796)

  • 1. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
    Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
    Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome.
    Blanchard J; Bolognin S; Chohan MO; Rabe A; Iqbal K; Grundke-Iqbal I
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1070-9. PubMed ID: 22082658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium rescues synaptic plasticity and memory in Down syndrome mice.
    Contestabile A; Greco B; Ghezzi D; Tucci V; Benfenati F; Gasparini L
    J Clin Invest; 2013 Jan; 123(1):348-61. PubMed ID: 23202733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
    Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
    Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.
    Stagni F; Magistretti J; Guidi S; Ciani E; Mangano C; Calzà L; Bartesaghi R
    PLoS One; 2013; 8(4):e61689. PubMed ID: 23620781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome.
    Begenisic T; Baroncelli L; Sansevero G; Milanese M; Bonifacino T; Bonanno G; Cioni G; Maffei L; Sale A
    Neurobiol Dis; 2014 Mar; 63():12-9. PubMed ID: 24269730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.
    Kleschevnikov AM; Belichenko PV; Faizi M; Jacobs LF; Htun K; Shamloo M; Mobley WC
    J Neurosci; 2012 Jul; 32(27):9217-27. PubMed ID: 22764230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.
    Bianchi P; Ciani E; Guidi S; Trazzi S; Felice D; Grossi G; Fernandez M; Giuliani A; Calzà L; Bartesaghi R
    J Neurosci; 2010 Jun; 30(26):8769-79. PubMed ID: 20592198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early environmental therapy rescues brain development in a mouse model of Down syndrome.
    Begenisic T; Sansevero G; Baroncelli L; Cioni G; Sale A
    Neurobiol Dis; 2015 Oct; 82():409-419. PubMed ID: 26244989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treadmill exercise restores memory and hippocampal synaptic plasticity impairments in ovalbumin-sensitized juvenile rats: Involvement of brain-derived neurotrophic factor (BDNF).
    Mokhtari-Zaer A; Saadat S; Marefati N; Hosseini M; Boskabady MH
    Neurochem Int; 2020 May; 135():104691. PubMed ID: 31982414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome.
    Deidda G; Parrini M; Naskar S; Bozarth IF; Contestabile A; Cancedda L
    Nat Med; 2015 Apr; 21(4):318-26. PubMed ID: 25774849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
    Kazim SF; Blanchard J; Bianchi R; Iqbal K
    Sci Rep; 2017 Apr; 7():45561. PubMed ID: 28368015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
    Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
    Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.